PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Early diagnosis of melanomas is the most effective means of improving melanoma prognosis. We can arm the non-expert screeners with artificial intelligence but most artificial intelligence methods are somewhat impractical in a clinical setting given the lack of transparency. To provide a quantitative and algorithmic approach to lesion diagnosis while maintaining transparency, and to supplement the clinician rather than replace them, our digital analysis provides visual features, or, “imaging biomarkers” that can both be used in machine learning and visualized too.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Daniel S. Gareau, Charles Vrattos, James Browning, Samantha R Lish, Benjamin Firester, James G. Krueger, "AI-driven imaging biomarkers for sensory cue integration during melanoma screening (Conference Presentation)," Proc. SPIE 11230, Optics and Biophotonics in Low-Resource Settings VI, 112300U (9 March 2020); https://doi.org/10.1117/12.2550189